Simi Valley not worried about AeroVironment’s headquarters move
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Trade Desk shares up 5% after split
The Trade Desk’s previously announced 10-for-1 split of its common stock took when the market opened on June 17. The Ventura advertising technology company’s stock closed at $590.02 on June 16 and, after the stock split, shares opened at $59.14 the next morning. Shares were up about 5% during the first few hours of trading, Read More →
Startups take center stage at Cal Poly’s AngelCon
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
AeroVironment moves headquarters out of Simi Valley
Fifty years after it was founded and two and a half after it moved to Simi Valley, the drone developer and manufacturer AeroVironment is moving its headquarters to Arlington, Virginia, effective immediately. The company made the announcement with an early morning news release on June 15. “The greater Washington D.C. area is where many of Read More →
New name, new plan for economic growth at Vandenberg
People from the private and public sectors believe the newly renamed Vandenberg Space Force Base has the potential to shape the Central Coast economy, and on June 3, those leaders laid out the first phase of their plan. At the online event, REACH — the Regional Economic Action Coalition, a San Luis Obispo-based economic development Read More →
South Coast Biz Tech Awards return with same winners, new challenges
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s new drug could be a blockbuster
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
